Silence Therapeutics PLC SLN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 10:17 AM EST
26.40quote price arrow up+0.12 (+0.46%)
Volume
214
52 week range
15.00 - 28.06

...

Loading . . .

KEY STATS

  • Open26.40
  • Day High26.40
  • Day Low26.40
  • Prev Close26.28
  • 52 Week High28.06
  • 52 Week High Date02/22/21
  • 52 Week Low15.00
  • 52 Week Low Date11/05/20
  • Market Cap747.88M
  • Shares Out82.83M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Silence Therapeutics PLC News

There is no recent news for this security.

Latest SLN News From Our Partners

QUOTE FINDER

Profile

MORE
Silence Therapeutics plc is a United Kingdom-based ribonucleic acid (RNA) technology company. The Company is primarily involved in the research and development of pharmaceutical products. The Company's technology harnesses the body's natural mechanisms to create therapeutic effects within its own cells. The Company has a has a genetic toolkit with its own therapeutic payloads to modulate gene expression up as well as down in preclinical in vivo models, and delivery systems...
iain Ross
Non-Executive Chairman
Mark Rothera
President
Craig Tooman
Chief Financial Officer
Address
72 Hammersmith Road
London
W14 8TH
United Kingdom